Report cover image

Human Growth Hormone Deficiency (Ghd) Drug Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 130 Pages
SKU # APRC20352467

Description

Summary

According to APO Research, the global Human Growth Hormone Deficiency (Ghd) Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Human Growth Hormone Deficiency (Ghd) Drug include Teva Pharmaceutical Industries, Ltd, Merck KGaA, Eli Lilly and Company, Versartis Inc., Strongbridge Biopharma, Sandoz International GmbH (Novartis AG), Pfizer Inc, Opko Health, Inc. and Novo Nordisk A/S, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Growth Hormone Deficiency (Ghd) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Growth Hormone Deficiency (Ghd) Drug.

The report will help the Human Growth Hormone Deficiency (Ghd) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Human Growth Hormone Deficiency (Ghd) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Growth Hormone Deficiency (Ghd) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Growth Hormone Deficiency (Ghd) Drug Segment by Company

Teva Pharmaceutical Industries, Ltd
Merck KGaA
Eli Lilly and Company
Versartis Inc.
Strongbridge Biopharma
Sandoz International GmbH (Novartis AG)
Pfizer Inc
Opko Health, Inc.
Novo Nordisk A/S
LG Life Sciences
Ipsen S.A.
GeneScience Pharmaceuticals Co. Ltd
Genentech, Inc (Roche)
Ferring Pharmaceuticals
EMD Serono Inc.
Ascendis Pharma A/S
AnkeBio Co. Ltd
Human Growth Hormone Deficiency (Ghd) Drug Segment by Type

Somavaratan
Somapacitan
TransCon-hGH
Others
Human Growth Hormone Deficiency (Ghd) Drug Segment by Application

Children
Adults
Human Growth Hormone Deficiency (Ghd) Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Deficiency (Ghd) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Deficiency (Ghd) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Deficiency (Ghd) Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Growth Hormone Deficiency (Ghd) Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Growth Hormone Deficiency (Ghd) Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Growth Hormone Deficiency (Ghd) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

130 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size (2020-2031)
2.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales (2020-2031)
2.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Market Average Price (2020-2031)
2.3 Human Growth Hormone Deficiency (Ghd) Drug by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Somavaratan
2.3.3 Somapacitan
2.3.4 TransCon-hGH
2.3.5 Others
2.4 Human Growth Hormone Deficiency (Ghd) Drug by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Children
2.4.3 Adults
3 Market Competitive Landscape by Manufacturers
3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue of Manufacturers (2020-2025)
3.4 Global Human Growth Hormone Deficiency (Ghd) Drug Average Price by Manufacturers (2020-2025)
3.5 Global Human Growth Hormone Deficiency (Ghd) Drug Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Product Type & Application
3.8 Global Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Established Date
3.9 Global Human Growth Hormone Deficiency (Ghd) Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Teva Pharmaceutical Industries, Ltd
4.1.1 Teva Pharmaceutical Industries, Ltd Company Information
4.1.2 Teva Pharmaceutical Industries, Ltd Business Overview
4.1.3 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.1.5 Teva Pharmaceutical Industries, Ltd Recent Developments
4.2 Merck KGaA
4.2.1 Merck KGaA Company Information
4.2.2 Merck KGaA Business Overview
4.2.3 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.2.5 Merck KGaA Recent Developments
4.3 Eli Lilly and Company
4.3.1 Eli Lilly and Company Company Information
4.3.2 Eli Lilly and Company Business Overview
4.3.3 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.3.5 Eli Lilly and Company Recent Developments
4.4 Versartis Inc.
4.4.1 Versartis Inc. Company Information
4.4.2 Versartis Inc. Business Overview
4.4.3 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.4.5 Versartis Inc. Recent Developments
4.5 Strongbridge Biopharma
4.5.1 Strongbridge Biopharma Company Information
4.5.2 Strongbridge Biopharma Business Overview
4.5.3 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.5.5 Strongbridge Biopharma Recent Developments
4.6 Sandoz International GmbH (Novartis AG)
4.6.1 Sandoz International GmbH (Novartis AG) Company Information
4.6.2 Sandoz International GmbH (Novartis AG) Business Overview
4.6.3 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.6.5 Sandoz International GmbH (Novartis AG) Recent Developments
4.7 Pfizer Inc
4.7.1 Pfizer Inc Company Information
4.7.2 Pfizer Inc Business Overview
4.7.3 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.7.5 Pfizer Inc Recent Developments
4.8 Opko Health, Inc.
4.8.1 Opko Health, Inc. Company Information
4.8.2 Opko Health, Inc. Business Overview
4.8.3 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.8.5 Opko Health, Inc. Recent Developments
4.9 Novo Nordisk A/S
4.9.1 Novo Nordisk A/S Company Information
4.9.2 Novo Nordisk A/S Business Overview
4.9.3 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.9.5 Novo Nordisk A/S Recent Developments
4.10 LG Life Sciences
4.10.1 LG Life Sciences Company Information
4.10.2 LG Life Sciences Business Overview
4.10.3 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.10.4 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.10.5 LG Life Sciences Recent Developments
4.11 Ipsen S.A.
4.11.1 Ipsen S.A. Company Information
4.11.2 Ipsen S.A. Business Overview
4.11.3 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.11.5 Ipsen S.A. Recent Developments
4.12 GeneScience Pharmaceuticals Co. Ltd
4.12.1 GeneScience Pharmaceuticals Co. Ltd Company Information
4.12.2 GeneScience Pharmaceuticals Co. Ltd Business Overview
4.12.3 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.12.4 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.12.5 GeneScience Pharmaceuticals Co. Ltd Recent Developments
4.13 Genentech, Inc (Roche)
4.13.1 Genentech, Inc (Roche) Company Information
4.13.2 Genentech, Inc (Roche) Business Overview
4.13.3 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.13.5 Genentech, Inc (Roche) Recent Developments
4.14 Ferring Pharmaceuticals
4.14.1 Ferring Pharmaceuticals Company Information
4.14.2 Ferring Pharmaceuticals Business Overview
4.14.3 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.14.5 Ferring Pharmaceuticals Recent Developments
4.15 EMD Serono Inc.
4.15.1 EMD Serono Inc. Company Information
4.15.2 EMD Serono Inc. Business Overview
4.15.3 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.15.4 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.15.5 EMD Serono Inc. Recent Developments
4.16 Ascendis Pharma A/S
4.16.1 Ascendis Pharma A/S Company Information
4.16.2 Ascendis Pharma A/S Business Overview
4.16.3 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.16.5 Ascendis Pharma A/S Recent Developments
4.17 AnkeBio Co. Ltd
4.17.1 AnkeBio Co. Ltd Company Information
4.17.2 AnkeBio Co. Ltd Business Overview
4.17.3 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2020-2025)
4.17.4 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
4.17.5 AnkeBio Co. Ltd Recent Developments
5 Global Human Growth Hormone Deficiency (Ghd) Drug Market Scenario by Region
5.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2020-2031
5.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2020-2025
5.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2026-2031
5.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2020-2031
5.3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2020-2025
5.3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2026-2031
5.4 North America Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
5.4.1 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2020-2031)
5.4.3 North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
5.5.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2020-2031)
5.5.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2020-2031)
5.6.3 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
5.7.1 South America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2020-2031)
5.7.3 South America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2020-2031)
5.8.3 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2020-2031)
6.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2020-2031) & (K Units)
6.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2020-2031)
6.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2020-2031)
6.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2020-2031)
6.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2020-2031)
7 Segment by Application
7.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2020-2031)
7.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2020-2031) & (K Units)
7.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2020-2031)
7.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2020-2031)
7.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2020-2031)
7.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Human Growth Hormone Deficiency (Ghd) Drug Value Chain Analysis
8.1.1 Human Growth Hormone Deficiency (Ghd) Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Human Growth Hormone Deficiency (Ghd) Drug Production Mode & Process
8.2 Human Growth Hormone Deficiency (Ghd) Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Human Growth Hormone Deficiency (Ghd) Drug Distributors
8.2.3 Human Growth Hormone Deficiency (Ghd) Drug Customers
9 Global Human Growth Hormone Deficiency (Ghd) Drug Analyzing Market Dynamics
9.1 Human Growth Hormone Deficiency (Ghd) Drug Industry Trends
9.2 Human Growth Hormone Deficiency (Ghd) Drug Industry Drivers
9.3 Human Growth Hormone Deficiency (Ghd) Drug Industry Opportunities and Challenges
9.4 Human Growth Hormone Deficiency (Ghd) Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.